It is live. As of today — April 6, 2026 — Eli Lilly's LillyDirect platform is shipping Foundayo (orforglipron) directly to patients across the United States. This is the first oral GLP-1 pill you can take with food, at any time of day, with no fasting requirement. Self-pay price: $149 per month. With a commercial insurance savings card: $25 per month. Medicare Part D patients will pay $50 per month starting July 1 under the Bridge Program.
Foundayo received FDA approval on April 1 — the fastest new molecular entity approval since 2002 — and Eli Lilly moved from approval to first shipments in five days. That is unprecedented for a weight loss medication launch. Here is everything you need to know to get it today.
How to Order Foundayo Through LillyDirect
LillyDirect is Eli Lilly's direct-to-patient telehealth and pharmacy platform. It is the fastest way to get Foundayo right now, and for many patients it will remain the simplest option even after retail pharmacies begin stocking the drug later this month.
Step 1: Visit LillyDirect. Go to lilly.com/lillydirect and select Foundayo from the available medications. If you already have a Zepbound or Mounjaro prescription through LillyDirect, your existing provider can switch you to Foundayo without a new consultation.
Step 2: Complete a telehealth consultation. A board-certified physician will review your medical history, verify your BMI (30 or higher, or 27 or higher with a qualifying comorbidity), and write a prescription if appropriate. The consultation is included — no separate fee.
Step 3: Choose your payment method. Self-pay is $149/month. If you have commercial insurance, you can apply Eli Lilly's savings card at checkout to bring your out-of-pocket cost to $25/month. Medicare and Medicaid patients are not eligible for the savings card but will have access to the $50/month Bridge Program starting July 1.
Step 4: Receive your medication. LillyDirect ships via overnight delivery. Most patients who complete their consultation today will receive Foundayo within 1-3 business days.
One important note: LillyDirect currently ships to all 50 states, but telehealth prescribing regulations vary. If your state requires an in-person visit for controlled substance prescriptions, LillyDirect will connect you with a local provider. Foundayo is not a controlled substance, so most patients will qualify for the fully virtual pathway.
Retail Pharmacy Timeline
LillyDirect is not the only option — it is just the first. Here is when the major retail pharmacies are expected to begin dispensing Foundayo:
April 6 (today): LillyDirect — shipping now
Mid-April: CVS, Walgreens, and Walmart are expected to begin dispensing. Eli Lilly has confirmed that inventory has been pre-positioned at major distribution centers to avoid the shortage problems that plagued the Mounjaro and Zepbound launches.
Late April: Independent pharmacies and mail-order services should have stock. Express Scripts and Caremark have both confirmed Foundayo will be on their formularies.
May 2026: Full nationwide availability expected across all major pharmacy chains and PBMs.
If you have a preferred pharmacy and do not want to use LillyDirect, ask your doctor to write a standard prescription. You can check stock availability by calling your pharmacy directly — most are expecting shipments within the next 7-14 days.
What Foundayo Costs: Every Scenario
The pricing landscape for Foundayo is simpler than most GLP-1 medications because Eli Lilly clearly wants to compete on accessibility. Here is what you will actually pay depending on your situation:
Commercially insured with savings card — $25/month. This is the headline number and it is real. Eli Lilly's savings card covers the difference between your insurance copay and $25. Eligible for patients with commercial insurance who are not on a government-funded plan.
Self-pay through LillyDirect — $149/month. No insurance required. This includes the telehealth consultation, prescription, and overnight shipping. This is the price that makes Foundayo competitive with compounded semaglutide.
Self-pay at retail pharmacy — $799/month list price. Without the LillyDirect discount or a savings card, the list price is $799. Most patients will never pay this — it exists primarily for PBM negotiations.
Medicare Part D (starting July 1) — $50/month. Under the CMS Bridge Program, qualifying Part D enrollees will pay a flat $50/month for Foundayo, Wegovy, or Zepbound. Read our full [Medicare Bridge Program breakdown](/blog/medicare-glp1-bridge-what-to-know) for eligibility details.
Medicare Part D (before July 1) — varies by plan. Some Part D plans may add Foundayo to their formulary before the Bridge Program launches, but cost-sharing will vary widely. Check with your plan.
Medicaid — varies by state. Medicaid coverage for GLP-1 obesity medications is state-specific. Our [state-by-state GLP-1 coverage guide](/cost/semaglutide-by-state) tracks which states cover what.
For a complete comparison of every GLP-1 option's current pricing, see our [GLP-1 price war analysis](/blog/glp1-price-war-foundayo-wegovy-april-2026).
Foundayo vs. Every Other GLP-1 Option
Now that Foundayo is actually available, here is how it stacks up against every alternative on the market:
Foundayo vs. Oral Wegovy: Both are daily pills. Foundayo wins on convenience (no fasting) and price ($149 vs. $249 self-pay). Oral Wegovy wins on weight loss (13.6% vs. 12.4% in trials). In the real world, we expect adherence differences to close that gap — the pill you actually take beats the one you skip because you could not fast that morning. For a deeper comparison, read our [Foundayo FDA approval analysis](/blog/foundayo-fda-approved-oral-glp1-pill).
Foundayo vs. Injectable Wegovy: Injectable Wegovy produces 15-17% weight loss (standard dose) or 20.7% (Wegovy HD, the new 7.2mg dose). If maximum weight loss is your goal and you do not mind weekly injections, injectable Wegovy — especially HD — is still more effective. But Foundayo's daily pill format and lower price point make it the better choice for patients who want simplicity.
Foundayo vs. Zepbound: Zepbound (tirzepatide) is a dual GIP/GLP-1 agonist that produces 20-22% weight loss in trials — the highest of any single-agent GLP-1. It is also $1,060/month list price and requires weekly injections. Zepbound is the premium option for patients with insurance coverage or who want maximum efficacy. Foundayo is the accessibility option.
Foundayo vs. Compounded Semaglutide: Compounded semaglutide runs $100-299/month through telehealth providers — roughly the same price range as Foundayo. But compounded products face accelerating FDA enforcement, uncertain quality, and shrinking supply. We documented the latest crackdown in our [FDA compounding update](/blog/fda-compounding-crackdown-march-2026). Foundayo is FDA-approved, quality-controlled, and priced competitively. For most patients, the switch to Foundayo is a no-brainer.
Foundayo vs. Ozempic: Ozempic (semaglutide 1mg/2mg) is approved for type 2 diabetes, not obesity, but is widely prescribed off-label for weight loss. It produces 8-14% weight loss depending on dose. At $998/month list price, it is more expensive and less effective than Foundayo for weight management. The only reason to stay on Ozempic is if you need the diabetes indication for insurance coverage.
Dosing: What to Expect in Your First 12 Weeks
Foundayo uses a gradual dose escalation schedule to minimize side effects. Here is what your first three months look like:
Weeks 1-2: 3mg once daily — starter dose to assess tolerability
Weeks 3-4: 6mg once daily — first escalation
Weeks 5-8: 12mg once daily — intermediate dose where many patients begin seeing appetite suppression
Weeks 9-12: 24mg once daily — second intermediate dose
Week 13 onward: 36mg or 60mg once daily — maintenance dose (your prescriber will determine which based on your response and tolerability)
The most common side effects during dose escalation are nausea (28% of patients in trials), diarrhea (18%), and decreased appetite (15%). These typically peak during the first 4-6 weeks and resolve as your body adjusts. Taking Foundayo with food — which you are free to do — significantly reduces nausea for most patients.
One key difference from injectable GLP-1s: because Foundayo is taken daily rather than weekly, dose adjustments happen faster. If you experience persistent nausea, your prescriber can hold at your current dose for an extra week or two before escalating, without the disruption of changing injection schedules.
Who Should NOT Take Foundayo
Foundayo is not appropriate for everyone. The FDA labeling includes the following contraindications:
Personal or family history of medullary thyroid carcinoma (MTC) — This is a standard GLP-1 class warning based on rodent studies showing thyroid C-cell tumors at high doses. The relevance to humans is unclear, but the contraindication stands.
Multiple endocrine neoplasia syndrome type 2 (MEN 2) — Related to the MTC risk above.
Known hypersensitivity to orforglipron or any excipient — Standard drug allergy contraindication.
Pregnancy or planned pregnancy — GLP-1 medications are not approved for use during pregnancy. If you are planning to become pregnant, discuss discontinuation timing with your prescriber. For more on this topic, read our [GLP-1 and pregnancy safety guide](/safety/ozempic-pregnancy).
Active pancreatitis — GLP-1 medications may increase the risk of pancreatitis. If you have a history of pancreatitis, discuss the risks with your provider.
Foundayo has not been studied in combination with insulin or sulfonylureas. If you are on diabetes medications, your prescriber may need to adjust doses to avoid hypoglycemia.
What To Do Right Now
If you have been waiting for an affordable, convenient oral GLP-1 option — today is the day. Here is your action plan:
If you want the fastest route: Go to LillyDirect, complete a telehealth consultation, and order Foundayo at $149/month (or $25/month with insurance savings card). You will likely have the medication in hand within 1-3 business days.
If you prefer your own doctor: Call your primary care provider or endocrinologist and ask them to write a Foundayo prescription. Retail pharmacy availability starts mid-April, so your pharmacy should have stock within 1-2 weeks.
If you are on Medicare: Mark July 1 on your calendar. The Bridge Program will cover Foundayo at $50/month through Part D. Unless your prescriber recommends starting sooner for medical reasons, waiting 12 weeks will save you significant money. Read our [CMS Balance Model explainer](/blog/cms-balance-model-medicare-glp1-2026) for full details.
If you are currently on compounded semaglutide: This is your off-ramp. Foundayo at $149/month is price-competitive with most compounded options and comes with FDA oversight, consistent quality, and zero regulatory risk. Talk to your provider about transitioning.
If you are currently on another GLP-1 and happy with it: There is no urgent reason to switch. Foundayo is a great option for new patients and for anyone frustrated with injection schedules or fasting requirements, but if your current therapy is working, stay the course.
For our full ranking of the best GLP-1 telehealth providers — including which ones are already prescribing Foundayo — see our [best providers page](/best). To compare costs across every option, check our [cost tracker](/cost). And for clinical deep dives on orforglipron's mechanism, trial data, and side effect profile, read our [how GLP-1 works guide](/guides/how-glp1-works).
The GLP-1 market just got its most accessible option yet. A daily pill, no fasting, $149 self-pay, $25 with insurance. This is what affordable weight loss medication looks like.